Lipidomics is a distinct subspecialty of metabolomics concerned with hydrophobic molecules that organize into membranes. Most of the lipid classes present in Mycobacterium tuberculosis are found only in Actinobacteria and show extreme structural diversity. This article highlights the conceptual basis and the practical challenges associated with the mass spectrometry-based lipidomic study of M. tuberculosis to solve basic questions about the virulence of this lipid-laden organism.
METABOLOMICS AS A DISCIPLINE Genes to Proteins to Metabolites
Genomics, transcriptomics, proteomics, and metabolomics are disciplines that broadly measure an organism's molecular repertoire to provide a portrait of that organism at an instant in time or a series of pictures to describe organism response. Working downstream from genes and enzymes, metabolites comprise the majority of the nonwater biomass of the cell. Transcriptomics and proteomics study linear polymers, so the key information is the sequence of building blocks comprised of nucleotides or amino acids. Accordingly, proteins, DNA, or RNA can be studied by applying one detection method to one general type of molecule to determine its sequence.
In contrast, metabolites are small molecules that show extreme diversity in their atomic composition. Metabolites are composed of aliphatic hydrocarbons, peptides, sugars, purines, pyrimidines, and other constituents in which individual molecules vary in length, oxygen functions, and other defined chemical elements. A conceptual challenge to inventing metabolomics platforms is that any chemical organizing principle of metabolites is not obvious or self-defining. Therefore, the reporting of organism-wide metabolite profiles requires that all investigators in the field agree on organizational systems for grouping metabolites together. Cellular metabolites can be organized based on the similarity of their chemical structures, as seen in the LIPID MAPS initiative, or by laying out the sequential relationships of substrates, enzymes, and products into biosynthetic pathways (1, 2) . A further practical challenge in building effective metabolomics platforms relates to the atomic diversity of metabolites, which require different solvents and separation techniques for individual subclasses of metabolites, such as nucleotides, peptides, and lipids.
In the past decade, these basic problems in organizing and detecting metabolites in high throughput have been largely solved, giving rise to functioning experimental platforms for metabolomics, which represent the youngest of the major systems biology disciplines. Metabolomics platforms take advantage of nuclear magnetic resonance (NMR) spectroscopy and mass spectrometry (MS) as nearly universal detection methods. Based on the implementation of increasingly comprehensive metabolite databases, it is now possible to rapidly profile thousands of metabolites in one experiment to generate an organism's or cell's metabolome. Here we highlight the conceptual and practical basis of metabolomics as a discipline, focusing on the mass spectrometric detection of lipids in the pathogen Mycobacterium tuberculosis to solve basic questions about the virulence of this lipid-laden organism.
Lipidomics as a Subspecialty of Metabolomics
Metabolomics assumes a practical definition as the highthroughput study of nonprotein, non-DNA, non-RNA cellular intermediates, which emphasizes small molecules with atomic masses lower than 3,000. Lipidomics emerged as a distinct subspecialty of metabolomics, which recognizes that conventional metabolites and lipids differ in one essential property: solubility in aqueous solutions. Conventional metabolomics focuses on molecules that are soluble in the cytosol, whereas lipidomics is mainly concerned with water-insoluble molecules that organize into membranes. Practical issues related to differences in methods needed to recover cytosolic metabolites and lipids increasingly lead to splitting of metabolomics and lipidomics into meaningfully different subfields with different biological foci. As contrasted with cytosolic metabolites, lipids tend to have more aliphatic hydrocarbons, larger size, lower polarity, and slower turnover (Fig. 1 ). These differences translate into a need for hydrophobic solvents, distinct ionpairing reagents, and chromatographic and MS ionization methods that are matched to the chemical properties of lipids. Lipids can be described in a general way as molecules composed of a polar head group of variable size linked to aliphatic hydrocarbon chains ( Fig. 2 ). Each lipid subclass is often comprised of different acylforms or alkylforms that possess the same core structure but differ in the length, saturation state, or substitution of the aliphatic chains. Thus, a lipidome of a single organism might contain up to 100,000 individual molecular lipid species (3) (4) (5) .
ORGANISM-WIDE LIPIDOMIC DETECTION Early Methods
Although lipidomics is a young specialty of systems biology, development of new databases and methods now creates technically mature platforms, which can broadly detect the named and unnamed components of a cell or bacterium within hours. Several efficient separation and detection methodologies are commonly used for the profiling of lipid repertoires including gas chromatography-MS (GC-MS) (6), liquid chromatography-MS (LC-MS) (7) , and NMR (8) . Early methods for lipidomics were thin-layer chromatography (9) and high-performance liquid chromatography (HPLC) interfaced with optical detection systems (10) . Such approaches are time-consuming and lack high sensitivity. Furthermore, these methodologies are mainly suitable for the characterization of global changes among lipid classes, rather than detection of detailed remodeling of individual molecular species in one lipid class. Detection of lipid fine structure is important because the biological activities of a given lipid class often depend on the structure and distribution of molecular species that differ in chain length, saturation, oxygenation, and other aspects of their fine molecular heterogeneity (11, 12) .
NMR
Modern lipidomic approaches are based on MS or NMR. NMR is a nondestructive and quantitative methodology, which provides stereo-and regiochemical information (13) . However, the disadvantage of NMR spectroscopy is its relatively low sensitivity, for which optimal analysis is limited to lipids analyzed in the micromolar range. Furthermore, NMR of cellular extracts emphasizes signals that can be unambiguously assigned to individual molecules in a mixture. Thus, NMR is typically used as a fingerprint analysis or to describe a defined set of molecules of a complex lipid extract rather than as a comprehensive description of all metabolites in a cell (14, 15) .
MS
Based on its high sensitivity, broad detection of naturally occurring lipids, and high dynamic range, MS has emerged as the most widely used lipidomic methodology. MS has pushed the field forward so that thousands of distinct lipid species can be separately detected in one experiment as unnamed accurate-mass retention time (AMRT) values (16) . Ionization of lipids can be performed on many types of platforms including electrospray ionization (ESI), atmospheric pressure chemical ASMscience.org/MicrobiolSpectrum 3 Mycobacterial Lipidomics ionization (APCI), atmospheric pressure photoionization, and matrix-assisted laser desorption ionization (MALDI). These techniques differ in their efficiencies of ionization and ability to maintain intact molecular structures during ionization, and thus can be matched to the lipidomic application, depending on the size and the structure of the molecules of biological interest. Currently, the most commonly employed configurations use ESI, a relatively gentle and sensitive ionization method that can be combined with many types of mass analyzers such as triple quadrupole, ion trap, Fourier transform (FT), and time of flight (TOF) devices, working in full scan mode or in collision-induced dissociation mode for tandem MS (MS/MS). ESI detects intrinsically charged molecules. Some lipids, such as polyketides and alcohols, are neutral in charge and thus are detected based on the formation of positive or negative adducts with ammonium, lithium, sodium, or other salts added to solvents. Ionization in the positive mode allows detection of the diverse lipids that possess an inherent positive charge or neutral species that adduct cations. The negative mode offers preferential detection of anionic free fatty acids, phospholipids, or sulfolipids. Accordingly, lipidomics of mammalian cells, which are predominantly composed of anionic membrane lipids, emphasizes negative mode detection. In contrast, the abundance of neutral polyketides and glycolipids in the mycobacterial cell envelope, especially its mycolate outer membrane (MOM), results in a greater analytical coverage of lipids by measuring ions in the positive mode (17, 18) .
TARGETED AND GLOBAL LIPIDOMICS Targeted Lipidomics
Targeted lipidomics involves conventional analytical chemistry experiments that emphasize analysis of the many molecular variants that belong to one lipid class. After extracting all classes of lipids from cells, each type of lipid is separated by specialized, class-specific chromatographic techniques. The goal of NMR or MS is to identify alterations in length, oxygen, or other chemical substitutions within one or a few related lipid classes. For example, the LIPID MAPS consortium uses a targeted approach for the study of all major membrane lipids in which lipid classes are separately analyzed using distinct LC-MS and MS/MS protocols (http://www .lipidmaps.org/protocols/index.html) (19) . As an illustration, atmospheric pressure chemical ionization (APCI) favors the ionization of the most hydrophobic lipids such as triglycerides, whereas ESI with negative ion mode scanning is favored for anionic membrane phospholipids. Therefore, these two classes of lipids can be separated and then analyzed by chromatographic and ionization methods that are optimized for each class. Table 1 summarizes published examples of targeted lipidomics in which class-specific analyses are carried out to analyze micro-heterogeneity of lipid structures or enzyme products with limited diversity.
In targeted lipidomics, specific lipids can be detected and measured by searching for defined fragmentation patterns in parent ion scanning, daughter ion scanning, or neutral loss scanning (5) . For LC-MS strategies performed on quadrupole or Q-TOF analyzers, specific measurements of targeted lipids eluting from a chromatographic column at any time are achieved by repeatedly scanning for selected reactions, a method called multiple reaction monitoring (20) . A sensitive and specific scanning mode is called selected reaction monitoring, whereby both specified parent and daughter ions are monitored. These multidimensional MS analyses are emerging as a dominant tool in targeted lipidomic analyses of glycerolipids, phospholipids, and sphingolipids (21) (22) (23) (24) . These targeted methods are notable for their quantitative accuracy and high sensitivity. Such targeted methods are useful when an a priori goal assumes that only one or a few types of lipids are relevant to a biological problem.
Global Lipidomics
However, for biological questions in which the organism is perturbed by a drug, or growth condition or genetic deletion, the types of lipids that might change in response to the biological variable cannot typically be predicted from the outset of the experiment. Carrying out dozens of targeted analyses for each lipid class is impractical, so untargeted, or "global," methods that nearly simultaneously measure most or all lipid classes are needed. Global methods emphasize nearly comprehensive methods of lipid extraction, separation, and detection. Although truly universal metabolomic analysis in one detection system has not yet been realized, existing HPLC-MS methods provide broad detection of thousands of diverse metabolites in dozens of classes in a single experiment. Development of such untargeted methods of lipidomics has been optimized against a broad spectrum of lipids derived from one type of cell (17, 18) . Untargeted lipidomics platforms typically use shotgun methods that avoid pre-separation of lipids prior to mass detection (25) or use normal phase chromatography with steep solvent gradients so that highly Downloaded from www.asmscience.org by IP: 54.70.40.11
On: Sat, 01 Feb 2020 07:26:28 dissimilar molecules are rapidly analyzed using one chromatographic profile (17) .
Shotgun and Separation Methods
Shotgun methods for untargeted lipidomics can use tandem quadrupole instruments for high throughput introduction of unfractionated lipid extract into the mass spectrometer (5), resulting in nearly simultaneous ionization of all analytes. Although rapid and simple, direct ionization of chemically diverse compounds present in an unfractionated preparation leads to crosssuppression effects and provides less quantifiable data (26, 27) . To partially overcome this limitation, chromatographic separation of compounds prior to their ionization and MS detection provides advantages over shotgun methods for the analysis of complex lipid mixtures (17, 28) . Chromatographic separation decreases the complexity of lipids being ionized at any moment in time, thus reducing the potential for ion suppression and increasing sensitive and quantitative detection of minor lipids or poorly ionizing lipid species within complex mixtures (29) . Mycobacteria, however, create special challenges in performing untargeted lipidomic studies, as their lipid repertoire ranges from highly apolar polyketides, such as phthiocerol dimyco-cerosates (PDIM), to highly polar phosphatidylinositol mannosides (PIM) ( Fig. 3 ). One normal phase chromatography method has been reported which uses one HPLC-MS method to separate 30 classes of mycobacterial lipids among more than 5,000 detected lipid species present in replicate HPLC-MS runs (17) .
Comparative Lipidomics: Aligning Data Sets
Comparative lipidomics typically involves solving a lipidome in replicate before and after introducing a biological variable, such as gene deletion, nutrient deprivation, or drug treatment (Fig. 4 ). The resulting lipidomic data sets typically contain thousands of molecular features, also called molecular events. A molecular feature is a threedimensional data point of connected m/z, retention time, and intensity data that describes one reproducibly detected ion, or when isotopic data are pooled, describes one compound ( Fig. 5 ). Data sets collected before and after the biological intervention are compared so that any two events in different data sets with equivalent mass and retention time are considered to be the same molecule and thus are aligned. Next, the ion intensity for each aligned data point is compared to calculate a fold-change ratio. Typically, intensity values are measured in replicate so that statistics can be applied on each comparison to generate P values for each molecular feature. This process is repeated hundreds or thousands of times to provide foldchange values to all features in the data set. Plotting foldchange versus P value provides a description of all features (ions or molecules) in the data set that are changed or not changed after applying the biological variable ( Fig. 4, middle panel) . This approach can be applied to the role of lipids in diseases, environmental perturbations, response to drugs, biomarkers, and genetics (27) . The sensitivity (femtomole) of modern mass spectrometers results in large data sets containing thousands of detected ions, which are analyzed in replicate and compared across multiple conditions such that the number of comparisons in a single experiment can exceed one million. Such analysis of large data sets to extract biological information is challenging and relies on bioinformatic tools previously developed in transcriptomics and other high-throughput biological platforms.
Quantitation
For targeted lipidomics, quantification is generally achieved by metabolic stable isotope labeling (30) or by addition of standards before extraction. Standards are often deuterated lipid species similar to the targeted lipid class, or a lipid species with odd-numbered carbon acyl chains that are naturally absent in the studied organism (31) . Using calibration curves and internal standards, programs perform automatic conversion of intensity values of targeted lipids to absolute mass to determine lipid concentrations in the sample (32, 33) . For untargeted comparative lipidomics, XCMS and other software programs perform semiquantitative analyses by interrogating ion intensities or the volume of intensive-time curves measured from ion chromatograms (34) . When analyzing hundreds or thousands of molecules in untargeted experiments, the use of internal standards is not feasible, so values are reported as ion intensity values of MS signals rather than absolute concentrations. The approach of reporting intensity values as a surrogate for measured concentrations relies on the high dynamic range of ESI-MS methods. Validation studies show that ion intensity values typically correlate with the concentration of the lipid in the sample across wide concentration ranges for most, but not all, lipids studied (17) . Such untargeted lipid screens are biologically powerful based on their breadth of coverage and speed in identifying many compounds, whose detected intensity changes after introducing bio-logical perturbations. Compounds reported as changed in such global lipidomic screens are typically subjected to detailed and quantitative analysis in a second round of confirmatory experiments.
Data Analysis and Display
Most approaches employ replicate biological analyses and automated ion finding algorithms that extract mass specific signals from noise, resulting in identification of discrete molecular features ( Fig. 4 and 5 ). Molecular events can be reliably tracked in experiments, whether or not the mass and retention time values are connected to chemical names. Once all molecular features are assigned, mean intensity values with calculated variance, the data sets are systemically aligned to identify those molecular features that change from one biological condition to another. This is accomplished through software packages that use multivariate statistics and pattern recognition methods, which take advantage of statistical procedures and visualization methods previously developed for transcriptomics (reviewed in reference 35). Multiple testing corrections limit the false discovery rate (36) . For example, MetaXCMS (R) allows comparison of multiple data sets from different biological conditions for the identification of metabolites that are specifically changed above threshold values after applying a biological variable (37) .
The entire inventory of lipids can be displayed according to fold-change values versus P values, which appear in "volcano plots" (Fig. 4, middle panel) . This common display visualizes the percent of all lipids in the inventory that meet threshold criteria for change and variance, and each feature encodes mass and retention time data that allow unnamed molecules of known mass to be named using mass databases or collisional MS. For example, comparing two mycobacterial strains before and after oxygen deprivation, gene deletion, or differing clinical origin allows detection of thousands of lipids from which only a few or many thousands can be shown to change (17, 18, 25, 38, 39) . Comparative metabolomic experiments of this type show whether the biological variable results in narrow or very broad cellular remodeling, and it provides the information from which changed compounds can be identified. Unnamed compounds of known mass with high change values can be named using databases that match observed accurate mass values to databases of known compounds. For previously unknown lipids, MS/MS can be performed to assist in identifying any lipid of interest ( Fig. 4, lower panel) . 
LIPID IDENTIFICATION Databases of Lipid Masses
Over the years, targeted analyses of lipids have provided accurate mass, fragmentation patterns, and polarity information for thousands of lipid species appearing in the literature. This experimental information has been compiled into databases for automatic identification of previously described or "known" lipids in newly acquired data sets (32, 40, 41) . Mass spectrometers with high resolution (10 -5 ) and mass accuracy (∼2 parts per million) enable elemental composition determination based on detected m/z. However, two molecules of the same nominal masses (isobars) within a mixture of lipids cannot be differentiated based on the m/z information and require MS/MS experiments to be identified. Identification of lipids based on interrogation of MS/MS data is lower throughput than automated interrogation of databases with MS data but can result in the discovery of new types of lipids. Software has been optimized for automatic lipid identification based on database queries, including Lipid Profiler/LipidView (20) , Lipid Inspector (42), Fatty Acid Analysis Tool (30) , and LipidQA (32) . LipidXplorer (43) carries out cross-platform interpretation of shotgun lipidomics data sets and identifies lipids via user-defined queries.
Mycobacterial Databases
Systematic organization of mycobacterial lipid classes shows that more than 90% of the defined lipid subclasses present in M. tuberculosis are found only in Actinobacteria. Mammalian cells, model eubacteria, and mycobacteria share a similar spectrum of phosphodiacylglycerols. However, the diverse mycolyl lipids, trehalose lipids, polyketides, and most other lipids found in mycobacteria are absent in non-mycobacterial model organisms (44) . Therefore, widely used databases comprised of mass values of lipids, including LIPID MAPS (Fig. 2) , provided little coverage for mycobacterial lipids. Therefore, rapid, automated naming of mycobacterial lipids was unavailable until recently. In 2011, three databases that focus specifically on genus-specific mycobacterial lipids were published: Mtb LipidDB, MycoMass, and MycoMap (17, 18, 39) . These tools have been integrated with LIPID MAPS and allow raw mass values to be compared to more than 100 classes of mycobacterial lipids (Mtb LipidDB, MycoMass) or detailed comparison to published mass, retention time, and collision spectra (MycoMap), facilitating rapid naming of mycobacterial lipids in global lipidomic profiling experiments.
MYCOBACTERIAL LIPIDS Plasma Membrane
Mycobacteria are characterized by a complex cell wall structure that is unusually rich in lipids that constitute up to 60% of the dry weight of the organism. These lipids organize into two fully formed permeability barriers, the cytosolic membrane and the MOM, that are separated by the cell wall core (Fig. 6 ). The plasma membrane is composed mainly of anionic phospholipids in a bilayer arrangement with proteins. The most abundant fatty acids in the plasma membrane are palmitic (C16:0), octadecenoic (C18:1), and 10-methyloctadecanoic (tuberculoestearic), which are largely carried on glycerol backbones, as mycobacteria do not produce sphingolipids. The most common phospholipids are phosphatidylglycerol, diphosphatidylglycerol, and phosphatidylethanolamine, because mycobacteria do not produce phosphatidylcholine.
Mycobacterium species also produce phosphatidylinositol and an abundance of phosphatidylinositol mannosides (PIMs) that show different levels of mannosylation and acylation ( Fig. 7) (45, 46) . PIM serves as the anchor for the biologically important lipoglycans lipoarabinomannan and lipomannan (47) (48) (49) . Despite their biological significance, lipoarabinomannan and lipomannan will not be discussed further due to their hydrophilic nature and high mass, which typically lead to their exclusion from apolar solvents and lipidomic detection methods that focus on lower-mass molecules.
The plasma membrane is also home to the menaquinones of the electron transport chain, including a unique sulfated menaquinone identified in M. tubercu- losis (50) . As with other prokaryotes, the plasma membrane of M. tuberculosis plays a central role in the biosynthesis of cell envelope structures and thus possesses a multitude of lipidic biosynthetic intermediates such as Lipid II, which carries subunits of peptidoglycan and is based on decaprenyl phosphate (51, 52) . This polyprenyl phosphate also carries subunits of arabinose, galactose, and mannose for the synthesis of the arabinogalactan, lipoarabinomannan, and glycoproteins (53) .
Periplasm
The cell wall skeleton of all mycobacteria is composed of peptidoglycan, a polymer of N-acetylglucosamine and N-muramic acid units (54, 55) . The peptidoglycan is covalently attached to arabinogalactan, which is in turn esterified to mycolic acids at the nonreducing end of the arabinan. Thus, the inner segment of the MOM is more like a polymer than a conventional membrane. Due to the high mass and a tendency not to extract in chloroform-based solvents, most global lipidomics methods do not extract and analyze peptidoglycan, arabinogalactan, or covalently linked mycolates.
Mycolate outer membrane
In addition to the abundant cell wall esterified mycolic acids that comprise the inner section of the MOM, noncovalently linked lipids form the outer segment of the MOM (Fig. 6 ). These extractable glycolipids and highly apolar structures on the outer surface are thought to form a pseudobilayer, with the cell wall intrinsic mycolic acids in the inner segment. Mycolic acids are composed of αand the β-hydroxy meromycolic chains that vary in length, oxygen modifications, and branching within and among Mycobacterium species (56) . In many cases the length, unsaturations, and substitutions present on mycolic acids are sufficient to distinguish among mycobacterial species and thus represent useful chemotaxonomic information (57) . M. tuberculosis has three major classes of mycolic acid: α-mycolic acid (di-cis cyclopropanated), keto-MA (α-methyl branched ketone and cis, trans cyclopropanated), and methoxy-MA (methyl ether and cis, trans cyclopropanated) (58) . One of the largest groups of extractable surface mycobacterial glycolipids are those based on trehalose (Fig. 8) trehalose monomycolate (TMM). The former was originally described as a cord factor and was proposed as one of the first virulence factors of M. tuberculosis (59) (60) (61) (62) . Trehalose dimycolate is a potent immunostimulatory molecule that acts through the lectin Mincle (63) . A second group of acylated trehalose lipids includes diacyl-, triacyl-, and polyacyltrehalose ( Fig. 8)  (64-66) . These structures are characterized by the presence of di-and tri-methyl branched fatty acids. The polyacyltrehalose has only been described in the M. tuberculosis complex (67) . The sulfolipids are the third group of acylated trehalose molecules (Fig. 8) . These sulfatides are defined by a 2′-sulfated trehalose that can be di-, tri-, or tetraacylated. The tetraacylated sulfolipid 1 (SL-1) is the most abundant form, and it is esterified with one palmitate or stearate, two hydroxyphthioceranate, and one phthioceranate group. Although this group of lipids was first recognized in 1959 (68) and was described as an M. tuberculosis complexspecific factor (69), a detailed understanding of the complexity and heterogeneity within this group was only recently achieved (70) (71) (72) (73) . The surface of M. tuberculosis is populated with other amphipathic lipids esterified with mycolic acids; these include glucose monomycolate (74) and glycerol monomycolate (75) . These two lipids have not been well studied with regard to their physiological role in M. tuberculosis, but glucose monomycolate is produced in vivo from host glucose, and both of these lipids are well recognized as glycolipid antigens presented by CD1 proteins (75) (76) (77) . A final group of abundant cell surface lipids are the acylated polyketide diols that are based on a phthiocerol or the keto-modified phthiodiolone backbone (Fig. 3) . These physiologically important lipids include the highly hydrophobic phthiocerol dimycocerosates (PDIM A) and phthiodiolone dimycocerosates (PDIM B). The phthiocerol dimycocerosates are structurally related to the phenolic glycolipids (PGL) (78, 79) . Mycobacterium bovis produces a monoglycosylated PGL termed Mycoside B, while M. tuberculosis produces multiglycosylated PGL (80).
MYCOBACTERIAL LIPIDOMIC METHODS Mycobacterial Lipids Differ from Those in Other Cellular Organisms
It is notable that the majority of M. tuberculosis lipids are limited in production to Actinomycetales, and many of these genus-specific lipids are large uncharged neutral lipids that accumulate in the MOM (Fig. 3, 6-8 ). Such mycolyl lipids, polyketides, and other neutral lipids require specialized extraction solvents, ionization conditions, and detection methods that are quite different than those used for anionic phospholipids that are the most abundant lipids in other organisms. For example, whereas the anionic phospholipids that dominate the plasma membranes of most cells are analyzed in the negative ion mode, neutral lipids that dominate the surface of mycobacteria form proton, sodium, and ammonium adducts that are detected in the positive mode. The hydrophobic nature and relatively high mass of mycolyl lipids and long chain polyketides generally require chloroform-based extraction solvents, addition of cations to run solvents, and ESI ionization conditions characterized by high voltage and low countercurrent gas (17, 18) .
Bioinformatic Methods
To support rapid methods of compound naming, the observed and expected m/z of potential ionization adducts of nearly all mycobacterial lipid structures described in the literature has been assembled into databases: Mtb LipidDB (18) and MycoMass (17) . They have cataloged more than 5,000 theoretical lipid species classified according to the LipidMaps standardized nomenclature based on eight lipid classes: fatty acyl lipids, glycerolipids, glycerophospholipids, sphingolipids, sterol lipids, prenol lipids, saccharolipids, and polyketides (40, 81) (Fig. 2) . These databases allow matching of detected lipids to the m/z values for thousands of known and predicted lipid structures. Analysis of M. tuberculosis total lipid extracts by LC-(ESI)MS typically detects between 2,000 and 10,000 molecular features, of which 75 to 90% do not match mass values in these mycobacterial lipid databases (17, 18, 38, 82) .
Annotating the M. tuberculosis Lipidome
This consistent finding indicates that, unlike mammalian cells and model Gram-negative bacteria, the annotation of the M. tuberculosis lipidome is far from complete. Sartain et al. noted that the lipids that could be identified using databases account for up to 75% of the total ion volume of a typical LC-MS data set (18) . The detection of thousands of ions not matching database entries suggests that automated annotation methods generally fail to match database compounds to ions of low intensity. In part, the high number of unannotated features in the LC-MS data files can be explained by the fact that existing databases focus on the terminal products of each lipid pathway and do not include all biosynthetic intermediates. For example, mycobactins are abundant siderophores annotated in all databases, but the stepwise generation of intermediates resulting from stepwise additions of fatty acids, peptide, or polyketide components are not yet identified and connected to mass values in data sets (82) .
Minor lipid variants may also be missed since information used to populate the databases is based on earlier structural studies that likely describe only the most abundant products of a lipid group or use degradative methods such as hydrolysis to help define structures and that may remove highly labile and minor modifications such as acetylation of sugars. In addition, the products of certain lipid synthetic pathways remain unannotated, and little has been done to understand the turnover or products from the degradation of mycobacterial lipids. Unlike other widely studied model bacteria in which all key lipid biosynthetic genes are known, the functions of certain mycobacterial biosynthetic enzymes remain unknown. Thus, despite study of mycobacterial lipids dating back to the time of Robert Koch, there are likely additional mycobacterial lipids and biosynthetic pathways that remain to be discovered.
Needed Bioinformatic Tools
The identification of unannotated lipids can be facilitated by evaluating the products' retention time with respect to the annotated lipids. However, most laboratories use different chromatographic methods, so retention times are valid only within an individual method or research group. Thus, a long-term goal would be to perform annotation not only based on detected m/z and retention time, but based also on MS/MS in which parent ions and fragments provide a fingerprint of each molecule that would be useful in any laboratory. The MycoMap database reports collisional spectra for 30 mycobacterial lipid families, representing a start on this mapping project (17) . Additionally, interrogation and extraction of collisional spectra from the literature, or the ability of individual investigators to contribute collisional spectra to an organized database, would greatly facilitate efforts to catalog all lipid fingerprints. Other bioinformatic tools that are still needed include a facile graphical user interface to further enhance the ability to perform automatic lipid identification with MS data sets. One graphical user interface, termed MS-LAMP, that includes data from the existing mycobacterial lipid databases has been reported (83) .
BIOLOGICAL STUDIES USING LIPIDOMICS Lipid Fine Structure
An advantage of MS-based lipidomics is the ability to assess changes in the fine structure of lipid families in response to environmental stress. For example, Jain et al. reported that changes in the availability of methyl malonyl coenzyme A products among various in vitro and in vivo settings results in the production of sulfolipids and PDIM species with differing overall chain length (25) . This study provided insight into the mechanism of polyketide lengthening and the role of substrate availability in the final structures of lipids. By separately tagging each chain length and phthiocerol/ phthiodolone core variant to a distinct mass value and tracking all mass values in parallel through an experiment, it is possible to generate "fine molecular maps" that track changes in length and composition of every mass-based molecular variant in the family ( Fig. 9 ) (17, 18, 38) .
Another example of molecular diversity within one class of lipids is the PIM family found in M. tuberculosis (Fig. 3) . This glycolipid family possesses species that can contain from 1 to 6 mannose units and 2 to 4 acyl chains. Thus, the Mtb LipidDB contains approximately 4,100 entries for PIM that take into account all possible combinations of acylation and glycosylation as well as ionization adducts. To provide a baseline for future analyses, Hsu and colleagues (72, 73) provided a comprehensive MS profile of the PIM species of M. bovis BCG including collisional MS spectra that can be used to develop selected reaction monitoring or MRM methodologies. Similarly, the many lipid modifications of sulfolipids create hundreds of natural variants of this molecule (70, 84) .
Enzymology
Elucidation of biosynthetic pathways based on a stepwise understanding of enzyme and substrate function represents an area that is ideal for the application of lipidomics-based approaches. In the past, determining enzyme products in cells typically employed metabolic labeling and targeted in vitro assays with defined substrates to determine the products of enzymes. As noted in Table 1 , conventional targeted lipid biochemistry approaches are being supplemented with more sensitive lipidomic methods that provide more detailed structural data with regard to end products or intermediates. A broader approach, whereby the deletion of biosynthetic enzyme genes in bacteria is followed by lipidomic profiling to detect both proximal products produced by the enzyme and distal products influenced indirectly, will represent an important step in defining the biosynthetic pathways for mycobacterial lipids. In particular, where multiple enzymes have similar or overlapping functions or perform multiple functions, gene deletion followed by lipidomic analysis can identify the nonredundant functions of any enzyme. Also, by tracking molecules of known masses but unknown chemical names or structures, it is possible to discover previously unknown molecules controlled by an enzyme. For example, previously unknown antigenic forms of deoxymycobactins were discovered by lipidomic profiling of M. tuberculosis lacking mycobactin synthases (39) .
Drug Action
Similarly, lipidomic analysis of drug-treated bacteria can provide broader insights into the mechanisms of action. The action of isoniazid (INH) on the dehydratase step of fatty acid synthase II to prevent the formation of meromycolate precursors was confirmed by LC-MS and GC-MS of saponified fatty acids from treated M. tuberculosis cells. Specifically, these methodologies revealed a buildup of 3-hydroxy fatty acids and decreased meromycolate precursors (85, 86) . A combination of metabolic labeling and LC-MS of lipid extracts from nonradiolabeled M. tuberculosis demonstrated that adamantyl urea inhibited the translocation of TMM through the inner membrane via the MmpL3 transporter. The function of MmpL3 was confirmed through LC-MS analyses of the lipidomes of the conditional mutants grown under nonpermissive conditions (85, 86) .
In another example related to INH, early work assessed the incorporation of [ 14 C]acetate or [ 14 C]glycerol into the mycobacterial cell wall lipids and fatty acids by conventional methods (87, 88) . These studies showed the direct effect of INH on mycolic acid synthesis. Subsequently, it was discovered that INH inhibited the formation of long fatty acids (C27-C40 and C39-C56) that were proposed as precursors in the synthesis of mycolic acids (89, 90) . These early lipidomics studies ultimately allowed for the identification of InhA as the primary target of INH (91) .
Clinical Biomarkers
Mycobacterial lipids are attractive candidates as biomarkers of tuberculosis infection because of their limited structural overlap with human lipids (Fig. 2) . Also, compared to peptides, lipids are likely more refractory to rapid metabolism in the host. For example, mycolic acids are abundant, foreign, and chemically inert, making them a candidate as a diagnostic marker for tuberculosis (57, 92) . Mycolic acid and mycocerosic acid components of PDIM (93) have been detected in the sputum of human patients as derivatized products by HPLC (94) . More recently, MS was applied to underivatized mycolic acids isolated from human sputum, and MRM techniques were implemented to enhance the sensitivity and specificity of detection mycolic acid derivatives for tuberculosis infection (95, 96) . These targeted approaches are based on what is understood with regard to the abundant products produced by M. tuberculosis in culture. A more global analysis of diagnostic samples such as sputum, serum, and urine may reveal additional mycobacterial lipids that can serve as diagnostic markers.
SUMMARY AND CONCLUSION
As lipidomics methods have become technically mature, a series of larger goals are now in sight. A substantially complete M. tuberculosis lipidome, based on the LIPID MAPS organizational scheme (Fig. 2) will likely emerge in coming years. To achieve this goal, the field needs to determine the functions of presumed lipid synthases that are currently of unknown function and to identify the stepwise intermediates that lead to more than 100 major lipid end products. This core goal will likely be followed by solving lipidomes of medically or evolutionarily important mycobacteria other than M. tuberculosis. It should be possible to achieve systematic understanding of lipid variation among clinical strains of mycobacteria from patients and to detect mycobacterial lipids within patient tissue or blood samples. With a complete lipid map, it will be possible to chart comprehensively the specific relationships among the genes and enzymes that regulate lipids. The prospect of integration of genomic, transcriptomic, proteomic, and metabolomic platforms is being realized. A recent study of M. tuberculosis entering and exiting an in vitro model of hypoxemia dormancy revealed connections among fatty acid and branched chain catabolism that broadly influence the metabolic state of mycobacteria (38) . One lipidomic experiment of this type can generate more than one million data points, so development of better bioinformatics methods will be a key to success.
